Getty Images The low representation of women in clinical trials has led to some efficacy and safety differences between men and women being missed, reports Dr Shuang Zhou of the United States Food and Drug Administration (FDA). African-American women were particularly underrepresented in clinical trials of new antiretrovirals.
Read the full story at Aidsmap.
Source : Aidsmap
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.